معرفی
Associate Professor Robert Stirling is a Senior Respiratory Specialist at Alfred Health and an honorary academic at Monash University, Department of Medicine, Faculty of Medicine, Nursing and Health Sciences. He is the Lead Clinician at the Alfred Lung Cancer Multidisciplinary Meeting and treats patients at Epworth Health. His clinical and academic work focuses on allergy, immunology, and respiratory diseases, particularly lung cancer and chronic lung conditions.
His research interests include improving the quality of care in lung cancer, multidisciplinary cancer care models, chronic respiratory infections, and health outcomes measurement. He is the co-coordinating principal investigator and chair of the steering committee for the Victorian Lung Cancer Registry (VLCR), and has led national initiatives including expert consensus guidelines for lung cancer outcomes with the International Consortium for Health Outcomes Measurement.
Recent research trends show a strong focus on lung cancer quality indicators, multidisciplinary care effectiveness, biologic therapies in severe asthma, and access to novel treatments in mesothelioma and bronchiectasis. His publications span high-impact journals in respiratory and oncology fields, emphasizing patient-centered outcomes and real-world evidence.
- Australasian Society of Clinical Immunology and Allergy
- Thoracic Society of Australia and New Zealand
- International Association for the Study of Lung Cancer
- Australian Lung Foundation
- Southern Melbourne Integrated Lung Cancer Leadership Group
- Australasian Lung Cancer Trials Group
Robert Stirling is actively involved in clinical teaching at Monash University, supervising medical students and respiratory trainees. He has received research funding from the Victorian Cancer Agency and industry partners for clinical trials in bronchiectasis and lung cancer. His leadership in the Victorian Lung Cancer Redesign Program highlights his role in shaping public health policy.
He is affiliated with key research initiatives including the VLCR and the Jeffrey Modell Center for primary immunodeficiency, reflecting his dual expertise in respiratory medicine and clinical immunology. His work contributes to UN Sustainable Development Goal 3: Good Health and Well-Being.
